Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

178 projects found matching your search criteria :

  1. Defining The Role of Microbiome Mimicry in Type 1 Diabetes (T1D): a pilot study for Single-Cell Strain-characterisation ...

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr Marcin Lukasz Pekalski

    Wojskowy Instytut Medyczny

  2. Selective autophagy-mediated protein degradation as a potential therapeutic strategy for the treatment of inflammatory c...

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr hab. Monika Emilia Marcinkowska

    Uniwersytet Jagielloński

  3. Septal Pouch And Changes in EndoCardium increase the risk of Arterial Thromboembolism - The SPACE CAT Study

    Call: SONATA 20 , Panel: NZ5

    Principal investigator: dr Izabela Daniela Janus-Ziółkowska

    Uniwersytet Przyrodniczy we Wrocławiu

  4. Analysis of the effects of proteotoxic stress on cholesterol homeostasis and its associations with cardiovascular diseas...

    Call: OPUS 28 , Panel: NZ5

    Principal investigator: prof. Wiesława Elżbieta Widłak

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie

  5. Effect of Urolithin A on gut microbiota and intestinal integrity contributing to neuroprotective effects in a model of P...

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Olga Wojciechowska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  6. Evaluation of cardiac and peripheral arteries structure and properties for predicting cardiovascular complications in pa...

    Call: OPUS 2 , Panel: NZ7

    Principal investigator: prof. Andrzej Michał Wykrętowicz

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Lekarski I

  7. Analysis of pharmacokinetic, pharmacodynamic and molecular determinants of intolerance and resistance to the Janus kinas...

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: dr hab. Marta Katarzyna Karaźniewicz-Łada

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  8. Development of novel potential therapeutics in inflammatory bowel diseases based on nanoformulations employing senomodul...

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: prof. Jakub Jerzy Fichna

    Uniwersytet Medyczny w Łodzi

  9. Swine dysentery - searching for early disease markers and assessing B. hyodysenteriae infection course in naïve pigs and...

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Agata Janina Augustyniak

    Uniwersytet Przyrodniczy w Poznaniu

  10. REMIND HF - Evaluation of REmote Motivational INterviewing for Disease management in Heart Failure patients and their ca...

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: prof. Izabella Uchmanowicz

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

  11. In search for DNA methylation aberrations associated with susceptibility to ovarian cancer

    Call: OPUS 26 , Panel: NZ5

    Principal investigator: dr Malwina Magdalena Suszyńska

    Instytut Chemii Bioorganicznej PAN

  12. New biomimetic 3D materials for potential use in advanced therapies of bone tissue diseases - 3D BioBone

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr hab. Joanna Krystyna Kolmas

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny

  13. First-in-class dual modulators of necroptosis kinases and 5-HT6 receptors as an innovative approach to develop an effect...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: prof. Jadwiga Handzlik

    Uniwersytet Jagielloński, Collegium Medicum

  14. Targeting adenylate kinase 4 (AK4) as a new paradigm in the treatment of non-small cell lung cancer: discovery and evalu...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr Magdalena Wujak

    Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy

  15. Extensive analysis of the immunological profile of pediatric patients with acute lymphoblastic leukemia in order to iden...

    Call: PRELUDIUM 22 , Panel: NZ5

    Principal investigator: Anna Krętowska-Grunwald

    Uniwersytet Medyczny w Białymstoku

  16. Fingerprint of oxidative stress in coronary artery disease

    Call: OPUS 25 , Panel: NZ5

    Principal investigator: prof. Miłosz Jarosław Jaguszewski

    Gdański Uniwersytet Medyczny, Wydział Lekarski

  17. Differences in the glycoproteomic profile of acute myeloid leukemia (AML) between cytogenetic and risk groups according ...

    Call: PRELUDIUM 22 , Panel: NZ5

    Principal investigator: Tomasz Pieńkowski

    Uniwersytet Medyczny w Białymstoku

  18. Predictive Potential of Circulating MicroRNA Biomarkers in Patients with High Familial or Genetic Risk of Cancer

    Call: OPUS 25 , Panel: NZ5

    Principal investigator: prof. Wojciech Fendler

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  19. Amorphous Senolytics: A Breakthrough Approach in Senescence Modulation and Age-Related Disease Treatment

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Szymon Sip

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

  20. Search for novel IKK-β inhibitors in the context of diseases with neuroinflammatory origin – structure-based drug design...

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Emilia Aleksandra Sługocka

    Uniwersytet Jagielloński, Collegium Medicum

  21. Blood plasma microRNA profile as a basis for detecting Alzheimer's disease and dementia risk in pre-symptomatic individu...

    Call: OPUS 24 , Panel: NZ7

    Principal investigator: prof. Urszula Wojda

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  22. Potential of TH cell profiling in personalized multiple sclerosis treatmentplanning.

    Call: OPUS 24 , Panel: NZ7

    Principal investigator: dr hab. Katarzyna Donskow-Łysoniewska

    Uczelnia Łazarskiego

  23. Distribution of Ticks and Carnivore Effects

    Call: POLONEZ BIS 3 , Panel: NZ8

    Principal investigator: dr Nicolas Serge Catherine De Pelsmaeker

    Instytut Biologii Ssaków PAN

  24. Customized DNA-based nanocarriers to boost heart healing

    Call: M-ERA.NET 2022 , Panel: NZ7

    Principal investigator: dr Monika Bzowska

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  25. A double whammy for the NF-κB signalling pathway: development of TAK1 and IKKβ degraders against inflammation-driven dis...

    Call: OPUS 24 (LAP) , Panel: NZ7

    Principal investigator: dr hab. Anna Karolina Więckowska

    Uniwersytet Jagielloński, Collegium Medicum

  26. Environmental and epigenetic modifications and atopy and allergic diseases prevention in rural population at all ages - ...

    Call: OPUS 24 , Panel: NZ7

    Principal investigator: dr hab. Barbara Ewa Sozańska

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

  27. The effect of maternal treatment with metformin in pregnancy and lactation on programming metabolic adverse conditions i...

    Call: SONATA BIS 12 , Panel: NZ7

    Principal investigator: dr hab. Monika Słupecka-Ziemilska

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  28. Searching for natural bioactive farnesoid X receptor agonists and their role in parenteral nutrition-associated liver di...

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: dr hab. Maciej Jan Stawny

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  29. Brain cytochrome P450 as a new target for the treatment of neurological and psychiatric diseases. Studies with human neu...

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: prof. Władysława Anna Daniel

    Instytut Farmakologii PAN

  30. New positive allosteric modulators of EAAT2 glutamate transporter as candidates for treatment of neurological and psychi...

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: prof. Krzysztof Tomasz Kamiński

    Uniwersytet Jagielloński, Collegium Medicum

  31. Selective modulation of PPARγ signaling as a new therapeutic strategy for Alzheimer's disease

    Call: PRELUDIUM 21 , Panel: NZ7

    Principal investigator: Karolina Barbara Przepiórska-Drońska

    Instytut Farmakologii PAN

  32. Combination of FAAH inhibition with action via serotonin 5-HT6 receptor as pioneering approach to fight with Alzheimer D...

    Call: PRELUDIUM 21 , Panel: NZ7

    Principal investigator: Kinga Maria Czarnota-Łydka

    Uniwersytet Jagielloński, Collegium Medicum

  33. Effects of activation of cholinergic, noradrenergic, and serotonergic systems on respiratory impairment in Alzheimer's d...

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: dr hab. Katarzyna Kaczyńska

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  34. Polygenic risk score for adverse cardiac events in 8 year follow-up of LIPIDOGEN2015 population.

    Call: OPUS 22 , Panel: NZ5

    Principal investigator: prof. Maciej Banach

    Instytut Centrum Zdrowia Matki Polki

  35. Targeting UDP-glucose and P2Y14 receptor interaction for therapeutic modulation of inflammatory lung diseases

    Call: SONATA 17 , Panel: NZ7

    Principal investigator: dr Tadeusz Piotr Karcz

    Uniwersytet Jagielloński, Collegium Medicum

  36. Significance of coronary artery disease in patients with aortic stenosis undergoing transcatheter aortic valve implantat...

    Call: SONATA 17 , Panel: NZ5

    Principal investigator: dr Rafał Ryszard Wolny

    Instytut Kardiologii im. Prymasa Tysiąclecia Stefana Kardynała Wyszyńskiego

  37. Novel broad-spectrum central nervous system active substances: optimization of their multi-target profile

    Call: OPUS 22 , Panel: NZ7

    Principal investigator: dr hab. Agnieszka Anna Kaczor

    Uniwersytet Medyczny w Lublinie, Wydział Farmaceutyczny

  38. Species belonging to lichens and bryophytes as a useful source of biologically active compounds in therapy of skin disea...

    Call: PRELUDIUM BIS 3 , Panel: NZ7

    Principal investigator: prof. Sławomir Daniel Dresler

    Uniwersytet Medyczny w Lublinie

  39. Research of multifunctional compounds targeting neuroinflammation and cholinergic deficit in Alzheimer's disease

    Call: OPUS 22 (LAP) , Panel: NZ7

    Principal investigator: prof. Kinga Aleksandra Sałat

    Uniwersytet Jagielloński, Collegium Medicum

  40. Non-provitamin A carotenoids as a novel therapeutic strategy in intestinal failure associated liver disease (IFALD)

    Call: PRELUDIUM BIS 3 , Panel: NZ7

    Principal investigator: dr hab. Maciej Jan Stawny

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  41. Maternal obesity as a risk factor of autism spectrum disorder in offspring - in search of the role of the gut microbiota...

    Call: OPUS 22 , Panel: NZ5

    Principal investigator: dr Dawid Mateusz Gawliński

    Instytut Farmakologii PAN

  42. The role of intestinal CYP2E1 in pathophysiology of the gastrointestinal tract disorders: new therapies for leaky gut sy...

    Call: PRELUDIUM BIS 3 , Panel: NZ7

    Principal investigator: dr hab. Maciej Stawnisław Sałaga

    Uniwersytet Medyczny w Łodzi

  43. Antithrombotic, haemodynamic and redox effects of novel HNO donors

    Call: OPUS 22 , Panel: NZ7

    Principal investigator: dr hab. Karol Franciszek Kramkowski

    Uniwersytet Medyczny w Białymstoku

  44. Extracellular vesicles produced by Bifidobacterium as novel approach fortreatment of allergy diseases

    Call: OPUS 22 (LAP) , Panel: NZ7

    Principal investigator: dr hab. Sabina Barbara Górska

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  45. New graphene-based approach targeting the prion-like propagation of α-synuclein in Parkinson's disease.

    Call: SONATA BIS 11 , Panel: NZ7

    Principal investigator: dr hab. Małgorzata Kujawska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  46. A premotor disease signature for ALS

    Call: JPco-fuND2 Call 2021 , Panel: NZ7

    Principal investigator: dr Wojciech Kuban

    Instytut Farmakologii PAN

  47. Gut microbiota in hospitalized children and the risk prediction for nosocomial diarrhea – a nested case-control study.

    Call: PRELUDIUM 20 , Panel: NZ6

    Principal investigator: dr Jan Maciej Łukasik

    Warszawski Uniwersytet Medyczny

  48. Application of machine-learning to clinical and imaging data for prediction of adverse events in patients undergoing tra...

    Call: OPUS 21 , Panel: NZ5

    Principal investigator: dr Jacek Kwiecinski

    Instytut Kardiologii im. Prymasa Tysiąclecia Stefana Kardynała Wyszyńskiego

  49. New 3-methoxypropanamide derivatives in search of effective substances for the treatment of neurological diseases - epil...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Marcin Konrad Jakubiec

    Uniwersytet Jagielloński, Collegium Medicum

  50. Influence of gut flora-derived ellagitannins' metabolites- urolithins on pro-inflammatory activity of neutrophils in con...

    Call: PRELUDIUM 2 , Panel: NZ7

    Principal investigator: Jakub Patryk Piwowarski

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy